Legal Representation
Attorney
Erin E. Lewis
USPTO Deadlines
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 31, 2018 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Dec 31, 2018 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 29, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 3, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 3, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 14, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 1, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 23, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 23, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 23, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 18, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 18, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 18, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 11, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 10, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 6, 2017 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for treating respiratory conditions formulated for pulmonary delivery via inhalation; Drug delivery agents in the form of inhalable vapors that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of inhalants that release the active ingredients for a wide range of pharmaceuticals; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of acute and chronic pain; Prescription synthetic narcotics; Pain relief medication; Pharmaceutical preparations and substances for the treatment of endocrine, musculoskeletal, cardiovascular, cardiopulmonary, respiratory, neurological and psychiatric diseases and disorders; Pharmaceutical preparations for the treatment of substance abuse disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose; Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases, generated by or acting on the central nervous system; Pharmaceutical preparations and substances acting on the central nervous system
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005